Julie Pique
Overview
Explore the profile of Julie Pique including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
440
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Poullet Z, Pique J, Maarouf A, Boutiere C, Rico A, Demortiere S, et al.
Neurol Neuroimmunol Neuroinflamm
. 2022 Apr;
9(4).
PMID: 35473885
Background And Objectives: Pure relapsing short myelitis with clinical and paraclinical features suggesting multiple sclerosis (MS) has been described recently. Here, we evaluated the existence of this potential new form...
12.
Chen J, Huda S, Hacohen Y, Levy M, Lotan I, Wilf-Yarkoni A, et al.
JAMA Neurol
. 2022 Apr;
79(5):518-525.
PMID: 35377395
Importance: Recent studies suggest that maintenance intravenous immunoglobulin (IVIG) may be an effective treatment to prevent relapses in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD); however, most of these studies had...
13.
Januel E, De Seze J, Vermersch P, Maillart E, Bourre B, Pique J, et al.
Mult Scler
. 2021 Dec;
28(7):1155-1159.
PMID: 34931885
Introduction: Recent studies suggested that anti-CD20 and fingolimod may be associated with lower anti-spike protein-based immunoglobulin-G response following COVID-19 vaccination. We evaluated if COVID-19 occurred despite vaccination among patients with...
14.
Deschamps R, Pique J, Ayrignac X, Collongues N, Audoin B, Zephir H, et al.
Eur J Neurol
. 2021 Feb;
28(5):1659-1664.
PMID: 33528851
Background And Objective: The prognosis in myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is a matter of debate. Our aim was to assess the long-term outcomes of patients with MOGAD....
15.
Louapre C, Maillart E, Papeix C, Zeidan S, Biotti D, Lepine Z, et al.
Eur J Neurol
. 2020 Oct;
28(10):3461-3466.
PMID: 33103295
Background: Outcomes of coronavirus disease 2019 (COVID-19) in patients with neuromyelitis optica spectrum disorders (NMOSD) or myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), often treated with immunosuppressive therapies, are still unknown....
16.
Louapre C, Collongues N, Stankoff B, Giannesini C, Papeix C, Bensa C, et al.
JAMA Neurol
. 2020 Jun;
77(9):1079-1088.
PMID: 32589189
Importance: Risk factors associated with the severity of coronavirus disease 2019 (COVID-19) in patients with multiple sclerosis (MS) are unknown. Disease-modifying therapies (DMTs) may modify the risk of developing a...
17.
Vukusic S, Rollot F, Casey R, Pique J, Marignier R, Mathey G, et al.
JAMA Neurol
. 2019 Sep;
77(1):94-102.
PMID: 31479149
Importance: Risk of developing progressive multifocal leukoencephalopathy (PML) is the major barrier to using natalizumab for patients with multiple sclerosis (MS). To date, the association of risk stratification with PML...
18.
Abravanel F, Pique J, Couturier E, Nicot F, Dimeglio C, Lhomme S, et al.
J Infect
. 2018 Jul;
77(3):220-226.
PMID: 29966614
Objectives: Hepatitis E virus (HEV) is a major cause of acute hepatitis worldwide. However, our understanding of the source of contamination is incomplete and the frequency of neurological manifestations in...
19.
Dalton H, van Eijk J, Cintas P, Madden R, Jones C, Webb G, et al.
J Hepatol
. 2017 Jul;
67(5):925-932.
PMID: 28734938
Background & Aims: Hepatitis E virus (HEV) has been associated with a number of neurological syndromes, but causality has not yet been established. The aim of this study was to...
20.
Androdias G, Bernard E, Biotti D, Collongues N, Durand-Dubief F, Pique J, et al.
Ann Neurol
. 2017 Apr;
81(5):754-758.
PMID: 28437859
We report 5 cases of acute heart failure (AHF) related to multiple sclerosis (MS) relapses. AHF was inaugural in 3 patients, always preceded or accompanied by signs of brainstem dysfunction;...